August 03, 2021
07:45
–
There may be a drug against COVID-19 early next year. This was announced in the morning block of BNT by prof. Todor KantardzhievProf. Dr. Todor Veselov Kantardzhiev, MD, graduated from the Medical Academy – Sofia in 1981, as.
Everything on the topic:
Coronavirus epidemic (COVID-19) 25375
–He revealed that this pill will be like the anti-flu and can be taken immediately at the first symptoms and a positive test.
Otherwise, Prof. Kantardzhiev explained that the last calm month of COVID has passed. There are 393 new cases this morning.
There are still 20 days until there is a significant increase in the number of cases. In these 20 days it is good for people to be vaccinated“, called prof. Todor Kantardzhiev
Prof. Dr. Todor Veselov Kantardzhiev, MD, graduated from the Medical Academy – Sofia in 1981, as – consultant on the vaccination process at the Sofia Municipality.
According to him, in the fall, when there are many cases, vaccination will be risky.
“Because when a lot of people gather in one place to get vaccinated, a lot of them can get infected,” he said, and said again, “It’s very important to be vaccinated, we’ve been vaccinated, we won’t be afraid of that. that lies ahead. “
About half of the vaccines that were given in the country yesterday were given in the Sofia Municipality. Vaccination offices have been opened in 5 malls in recent months. There are also offices in two community centers in Sofia – in “Mladost” and in “Hristo Botev”. The most important thing is to motivate people from large groups to get vaccinated – such as those in food chains, public transport, etc.
Vaccines will be rhythmically supplied to the checkpoints, he added. Our country has signed an agreement for the coming years, if there is a change in the virus, to have modern and life-saving vaccines. So far, there are vaccines, but if many people suddenly decide to get vaccinated and the epidemic situation is risky, it is not good – it risks people’s health, repeated Prof. Kantardzhiev.
Current circulating strains do not require new vaccines, he said, because genetic lines are covered by vaccines. But with a new mutation, we have a contract with Pfizer for 2022-2023 for a modified vaccine against the new as yet unknown variants.
Kantardzhiev said that nothing is being done for the organization of hospital care, and we have another 20 days.
